Ionis Pharmaceuticals (IONS) Minority Interest (2009 - 2020)

Ionis Pharmaceuticals' Minority Interest history runs 5 years deep, the most recent figure standing at $223.2 million for Q3 2020.

• In Q3 2020, Minority Interest rose 38.08% year-over-year to $223.2 million; the TTM figure through Sep 2020 stood at $223.2 million (up 38.08% YoY), while the FY2019 annual figure was $213.5 million, up 53.47% from the prior year.
• Minority Interest for Q3 2020 stood at $223.2 million, up from $217.6 million in the prior quarter.
• The five-year high for Minority Interest was $223.2 million in Q3 2020, with the low at $84.3 million in Q4 2017.
• The 4-year median for Minority Interest is $161.7 million (2019), against an average of $157.2 million.
• The sharpest annual moves came in 2019 and 2020: Minority Interest soared 109.74% in 2019, then gained 15.87% in 2020.
• Ionis Pharmaceuticals' Minority Interest stood at $84.3 million in 2017, then surged by 65.05% to $139.1 million in 2018, then jumped by 53.47% to $213.5 million in 2019, then grew by 4.58% to $223.2 million in 2020.
• Business Quant data shows IONS's Minority Interest at $223.2 million in Q3 2020, $217.6 million in Q2 2020, and $210.2 million in Q1 2020.